Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1967 1
1970 2
1971 1
1972 1
1974 3
1975 1
1976 4
1977 3
1979 3
1980 4
1982 3
1983 1
1984 3
1985 4
1986 5
1987 4
1989 7
1990 3
1991 1
1992 3
1993 11
1994 6
1995 2
1996 6
1997 5
1998 3
1999 8
2000 1
2001 2
2002 3
2003 3
2004 1
2005 9
2006 6
2007 1
2008 5
2009 5
2010 1
2011 9
2012 13
2013 13
2014 11
2015 12
2016 19
2017 15
2018 24
2019 53
2020 50
2021 33
2022 34
2023 35
2024 21
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

459 results

Results by year

Filters applied: . Clear all
Page 1
Management of chronic urticaria in children: a clinical guideline.
Caffarelli C, Paravati F, El Hachem M, Duse M, Bergamini M, Simeone G, Barbagallo M, Bernardini R, Bottau P, Bugliaro F, Caimmi S, Chiera F, Crisafulli G, De Ranieri C, Di Mauro D, Diociaiuti A, Franceschini F, Gola M, Licari A, Liotti L, Mastrorilli C, Minasi D, Mori F, Neri I, Pantaleo A, Saretta F, Tesi CF, Corsello G, Marseglia GL, Villani A, Cardinale F. Caffarelli C, et al. Among authors: gola m. Ital J Pediatr. 2019 Aug 15;45(1):101. doi: 10.1186/s13052-019-0695-x. Ital J Pediatr. 2019. PMID: 31416456 Free PMC article.
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
Avallone G, Mastorino L, Tavoletti G, Macagno N, Barei F, Schena D, Rossi M, Magnaterra E, Antonelli F, Babino G, Viola R, Gargiulo L, Conforti C, Rapparini L, Errichetti E, Patruno C, Ruggiero P, Roccuzzo G, Maronese CA, Girolomoni G, Gola M, Chiricozzi A, Balato A, Ambrogio F, Narcisi A, Zalaudek I, Gurioli C, Napolitano M, Marzano AV, Foti C, Costanzo A, Piraccini BM, Ferrucci SM, Ortoncelli M, Quaglino P, Ribero S. Avallone G, et al. Among authors: gola m. J Am Acad Dermatol. 2024 May;90(5):1031-1034. doi: 10.1016/j.jaad.2024.01.004. Epub 2024 Jan 9. J Am Acad Dermatol. 2024. PMID: 38199282 No abstract available.
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
Gargiulo L, Ibba L, Malagoli P, Burroni AG, Chiricozzi A, Dapavo P, Ferrucci SM, Gola M, Napolitano M, Ortoncelli M, Rossi MT, Sciarrone C, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: gola m. Dermatol Ther (Heidelb). 2024 Apr;14(4):919-932. doi: 10.1007/s13555-024-01135-x. Epub 2024 Mar 21. Dermatol Ther (Heidelb). 2024. PMID: 38509380 Free PMC article.
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Gargiulo L, Ferrucci SM, Ibba L, Ingurgio RC, Alfano A, Amoruso GF, Balato A, Barbagallo T, Barei F, Bellinato F, Brianti P, Burroni AG, Campanati A, Caroppo F, Carugno A, Bello GD, De Franco F, Fortina AB, Foti C, Gaiani FM, Girolomoni G, Gola M, Guanti MB, Gurioli C, Legori A, Loconsole F, Magnaterra E, Malagoli P, Margiotta FM, Marzano AV, Mercuri SR, Milanesi N, Musumeci ML, Napolitano M, Ortoncelli M, Paolino G, Patruno C, Pella P, Pezzolo E, Prestinari F, Recalcati S, Ribero S, Rongioletti F, Rossi M, Satolli F, Savoia P, Sciarrone C, Spigariolo C, Stabile G, Tirone B, Tolino E, Zerbinati N, Potenza C, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: gola m. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e807-e811. doi: 10.1111/jdv.20699. Epub 2025 Apr 17. J Eur Acad Dermatol Venereol. 2025. PMID: 40247595 No abstract available.
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study.
Barei F, Macchi S, Calzari P, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, Ippoliti E, Gurioli C, Piraccini BM, Trave I, Cozzani E, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Campanati A, Gioacchini H, Pisapia A, Avallone G, Micali G, Musumeci ML, Ortega R, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Patruno C, Esposito M, Fargnoli MC, De Berardinis A, Ferreli C, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Lauletta G, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: gola m. Clin Exp Dermatol. 2025 Jun 20:llaf275. doi: 10.1093/ced/llaf275. Online ahead of print. Clin Exp Dermatol. 2025. PMID: 40578600
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, Barei F, Burroni AG, Caccavale S, Calzavara-Pinton P, Esposito M, Fargnoli MC, Ferrucci SM, Foti C, Girolomoni G, Gola M, Guanti MB, Gurioli C, Magliulo M, Maurelli M, Morrone P, Musumeci ML, Napolitano M, Ortoncelli M, Patruno C, Piraccini BM, Pezzolo E, Ribero S, Rossi M, Savoia P, Sciarrone C, Tirone B, Vaccino M, Veronese F, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: gola m. J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10. J Dermatolog Treat. 2024. PMID: 39389612 Free article.
The emerging role of Artificial Intelligence in proton therapy: A review.
Isaksson LJ, Mastroleo F, Vincini MG, Marvaso G, Zaffaroni M, Gola M, Mazzola GC, Bergamaschi L, Gaito S, Alongi F, Doyen J, Fossati P, Haustermans K, Høyer M, Langendijk JA, Matute R, Orlandi E, Schwarz M, Troost EGC, Vondracek V, La Torre D, Curigliano G, Petralia G, Orecchia R, Alterio D, Jereczek-Fossa BA. Isaksson LJ, et al. Among authors: gola m. Crit Rev Oncol Hematol. 2024 Dec;204:104485. doi: 10.1016/j.critrevonc.2024.104485. Epub 2024 Sep 2. Crit Rev Oncol Hematol. 2024. PMID: 39233128 Review.
Prospects of POLD1 in Human Cancers: A Review.
Gola M, Stefaniak P, Godlewski J, Jereczek-Fossa BA, Starzyńska A. Gola M, et al. Cancers (Basel). 2023 Mar 22;15(6):1905. doi: 10.3390/cancers15061905. Cancers (Basel). 2023. PMID: 36980791 Free PMC article. Review.
Interventions for atrophic rhinitis.
Mishra A, Kawatra R, Gola M. Mishra A, et al. Among authors: gola m. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008280. doi: 10.1002/14651858.CD008280.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336840 Free PMC article.
Letter: Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Lauletta G, Potestio L, Patruno C, Ferrucci SM, Angileri L, Barei F, Ortoncelli M, Ribero S, Girolomoni G, Malagoli P, Pezzolo E, Narcisi A, Gargiulo L, Guanti MB, Musumeci ML, Ortega R, Gurioli C, Campanati A, Caroppo F, Legori A, Rossi M, Tolino E, D'Erme AM, Milanesi N, Sciarrone C, Gola M, Magnaterra E, Grieco T, Satolli F, Loconsole F, Brianti P, Stingeni L, Hansel K, Bertoldi AM, Napolitano M. Lauletta G, et al. Among authors: gola m. Dermatitis. 2025 Jun 5. doi: 10.1089/derm.2025.0129. Online ahead of print. Dermatitis. 2025. PMID: 40470535 No abstract available.
459 results